First Time Loading...

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 32.08 CNY 0.82% Market Closed
Updated: May 3, 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Revenue
¥75.5B
CAGR 3-Years
7%
CAGR 5-Years
12%
CAGR 10-Years
16%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue?
Revenue
75.5B CNY

Based on the financial report for Dec 31, 2023, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue amounts to 75.5B CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been 7% over the past three years , 12% over the past five years , and 16% over the past ten years .